francesco paolo perelli (@fpperelli) profile picture
Joined February 2022
Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)Photo by francesco paolo perelli (@fpperelli)
📢 Long-term efficacy and safety of #LAAC vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomised controlled trials 👉 ow.ly/11Tw50Zu8iA @EuropaceEiC @GiulioConteMD @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhythmias #AF
7
64
5
153
19,808
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences. Discover more in #EHJ 👉 ow.ly/xgN550Z4Y1c @RoccoMontone @ehj_ed
26
3
73
27,313
francesco paolo perelli retweeted
Dantrolene shows promise as a safe, feasible strategy to prevent doxorubicin-induced #cardiomyopathy (DIC). Already used for malignant #hyperthermia, it may be repurposed for DIC prevention. jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc #cvPrev #CardioOnc
3
18
1
62
7,378
Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis ow.ly/B9Kk50YgtCO #EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @SukritiBanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX
27
1
77
5,697
francesco paolo perelli retweeted
❤️ 🧲CMR T2 mapping predicts survival in AL amyloidosis—even after strong treatment response. Myocardial edema flags hidden risk beyond biomarkers. pdf 👉 journalofcmr.com/article/S10… Dr. Yining Wang explains below 👇 #WhyCMR
3
6
395
francesco paolo perelli retweeted
The authors present the largest series of #TTVR after T-TEER with electrosurgical leaflet modification in a subset of patients. At 30 days, TR severity was markedly reduced, and substantial symptom alleviation occurred. jacc.org/doi/10.1016/j.jcin.… #JACCINT #vhdTR #TEER @jtsaxon
2
12
1
41
23,435
francesco paolo perelli retweeted
New in #JACCINT: 1-year results from the #CLASPIID trial show #MTEER benefits patients with degenerative MR across all cardiac damage stages 💪 Significant MR & #QoL improvements 🌟 low adverse events ⚡ and low mortality jacc.org/doi/10.1016/j.jcin.… #vhdMR #TEER @AbdullahAlabcha
1
14
1
42
6,251
francesco paolo perelli retweeted
2025 ACC Expert Consensus Decision Pathway on Evaluation & Management of Tricuspid Regurgitation @JACCJournals @ACCinTouch #TR #CardioX jacc.org/doi/10.1016/j.jacc.…
1
55
167
10,182
Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy – should we propose these patients to intervention? More on the potential outcomes in ow.ly/x9oM50X7Ify #EHJQCCO #AFib #HCM #PVI @cpgale3 @diogoasantosfer @m_piepoli
2
31
2
88
13,359
francesco paolo perelli retweeted
Mitochondrial cardiomyopathies This review discusses comprehensive overview of the pathophysiology, clinical features, diagnostic approaches, and treatment options for mitochondrial #CMP academic.oup.com/eurheartj/a… #CardioEd @ehj_ed @ESC_Journals
8
42
2,542
francesco paolo perelli retweeted
After 3 years of relentless hard work, passion, and dedication to #cvimaging and research in TR, our brilliant PhD student @michetomaselli has successfully defended his thesis! Michele, your fantastic journey has been inspiring for so many fellows and researchers that had the chance to work with you. The future is bright, and I’m honored to have been part of your path and to work with you daily. Congratulations—this is just the beginning! @lpbadano @ClementA25 @giorgio_oliver @Fraheilbron @Springhetti_P @fpperelli @GParati22 @TwittAuxologico @unimib #3DEcho #PhDSuccess #TricuspidRegurgitation #ProudMentor #FutureLeader
We celebrate @michetomaselli who succesfully defended his PhD thesis about the advanced assessment of patients with secondary TR. Fantastic redult of 3 years of hard work
4
8
1
51
3,750
Therapeutic left-to-right shunting in heart failure. A State-of-the-Art review just published in #EHJ 👉 ow.ly/OyHA50V3n25 @RoccoMontone @ehj_ed #heartfailure
1
40
88
7,037
francesco paolo perelli retweeted
In the EXPANDed studies, pts with moderate secondary mitral regurgitation (SMR) treated with M-TEER had improvements similar to subjects with severe SMR in #QoL and positive LV remodeling at 1 year. jacc.org/doi/10.1016/j.jchf.… #JACCHF #HeartFailure #TEER #HeartMonth @GilbertTangMD
1
18
1
53
8,537
Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics. Discover more in #EHJ 👉 ow.ly/YhPG50V17Az @RoccoMontone @ehj_ed
2
6
1
34
4,090
francesco paolo perelli retweeted
In pts undergoing 99mTc PYP imaging for suspected ATTR-CM, very low hs-cTnT & NT-proBNP levels can effectively rule out the diagnosis, although in a small subset of pts. jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc #CardioOnc #ATTR #hscTnT #NTproBNP #Amyloidosis @LauraDemichieli
1
10
45
7,039
francesco paolo perelli retweeted
T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 jacc.org/doi/10.1016/j.jcin.… #TEER #Cardiology #vhdTR @PhilippLurz
2
49
2
126
15,831
francesco paolo perelli retweeted
In moderate #aorticstenosis & asymptomatic severe AS, increased diffuse myocardial interstitial fibrosis on #whyCMR is associated with worse outcomes. jacc.org/doi/10.1016/j.jcmg.… #JACCIMG #vhdAS #CMR @PPibarot @ClavelLabo
2
39
2
96
12,145
francesco paolo perelli retweeted
Patients undergoing concomitant #PCI and #TAVR had higher major vascular complications, and slightly higher composite of all-cause mortality and stroke compared with those who underwent PCI within 90 days before the TAVR procedure. jacc.org/doi/10.1016/j.jcin.… #JACCINT
1
33
2
98
12,917